

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sphingosine metabolic process (GO:0006670) | 7.81135228 |
| 2 | diol metabolic process (GO:0034311) | 6.93221338 |
| 3 | sphingoid metabolic process (GO:0046519) | 6.20781198 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 5.21063877 |
| 5 | paraxial mesoderm development (GO:0048339) | 5.10627174 |
| 6 | response to muscle activity (GO:0014850) | 5.06796776 |
| 7 | plasma membrane repair (GO:0001778) | 5.03744198 |
| 8 | carnitine shuttle (GO:0006853) | 4.90757012 |
| 9 | sarcomere organization (GO:0045214) | 4.89644428 |
| 10 | cardiac myofibril assembly (GO:0055003) | 4.83335053 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 4.69049387 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.68882293 |
| 13 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 4.68128401 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 4.62017974 |
| 15 | skeletal muscle contraction (GO:0003009) | 4.60612709 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.58178959 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.55540362 |
| 18 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.52553305 |
| 19 | muscle filament sliding (GO:0030049) | 4.49835223 |
| 20 | actin-myosin filament sliding (GO:0033275) | 4.49835223 |
| 21 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.47624706 |
| 22 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 4.38773103 |
| 23 | myofibril assembly (GO:0030239) | 4.35824578 |
| 24 | response to inactivity (GO:0014854) | 4.34136113 |
| 25 | regulation of skeletal muscle contraction (GO:0014819) | 4.24415127 |
| 26 | protein-chromophore linkage (GO:0018298) | 4.23921561 |
| 27 | low-density lipoprotein particle clearance (GO:0034383) | 4.13869035 |
| 28 | collagen fibril organization (GO:0030199) | 4.13649117 |
| 29 | actin-mediated cell contraction (GO:0070252) | 4.09058598 |
| 30 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.04997930 |
| 31 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.04625993 |
| 32 | heart contraction (GO:0060047) | 4.00091591 |
| 33 | heart process (GO:0003015) | 4.00091591 |
| 34 | brown fat cell differentiation (GO:0050873) | 3.97333659 |
| 35 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.93756274 |
| 36 | protein heterotrimerization (GO:0070208) | 3.92376929 |
| 37 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.86638085 |
| 38 | regulation of relaxation of muscle (GO:1901077) | 3.83076792 |
| 39 | regulation of protein glycosylation (GO:0060049) | 3.81975352 |
| 40 | regulation of fatty acid oxidation (GO:0046320) | 3.78971638 |
| 41 | negative regulation of protein localization to cell surface (GO:2000009) | 3.77747557 |
| 42 | notochord development (GO:0030903) | 3.77701500 |
| 43 | regulation of pigment cell differentiation (GO:0050932) | 3.77642200 |
| 44 | SMAD protein complex assembly (GO:0007183) | 3.76749149 |
| 45 | regulation of cell communication by electrical coupling (GO:0010649) | 3.71575695 |
| 46 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.70272049 |
| 47 | tricarboxylic acid cycle (GO:0006099) | 3.67926382 |
| 48 | lipid particle organization (GO:0034389) | 3.65982090 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.60874171 |
| 50 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.58172548 |
| 51 | carnitine transmembrane transport (GO:1902603) | 3.57143529 |
| 52 | white fat cell differentiation (GO:0050872) | 3.49103647 |
| 53 | actomyosin structure organization (GO:0031032) | 3.45500622 |
| 54 | cardiac muscle cell development (GO:0055013) | 3.44376781 |
| 55 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.44271008 |
| 56 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.43815391 |
| 57 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.40224690 |
| 58 | regulation of sarcomere organization (GO:0060297) | 3.36989908 |
| 59 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.36046791 |
| 60 | cardiac cell development (GO:0055006) | 3.35842557 |
| 61 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.35171307 |
| 62 | regulation of meiosis I (GO:0060631) | 3.33218434 |
| 63 | striated muscle atrophy (GO:0014891) | 3.33157263 |
| 64 | actin filament-based movement (GO:0030048) | 3.32924063 |
| 65 | lipopolysaccharide metabolic process (GO:0008653) | 3.32229449 |
| 66 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.32218178 |
| 67 | DNA methylation involved in gamete generation (GO:0043046) | 3.32141668 |
| 68 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.31901349 |
| 69 | positive regulation of myotube differentiation (GO:0010831) | 3.30027093 |
| 70 | muscle system process (GO:0003012) | 3.28187945 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.25993301 |
| 72 | regulation of cofactor metabolic process (GO:0051193) | 3.25926904 |
| 73 | regulation of coenzyme metabolic process (GO:0051196) | 3.25926904 |
| 74 | biotin metabolic process (GO:0006768) | 3.24293163 |
| 75 | positive regulation of developmental pigmentation (GO:0048087) | 3.22333664 |
| 76 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22062158 |
| 77 | valine metabolic process (GO:0006573) | 3.21147029 |
| 78 | carnitine transport (GO:0015879) | 3.18549826 |
| 79 | amino-acid betaine transport (GO:0015838) | 3.18549826 |
| 80 | skeletal muscle fiber development (GO:0048741) | 3.18098203 |
| 81 | regulation of the force of heart contraction (GO:0002026) | 3.18034074 |
| 82 | skeletal muscle adaptation (GO:0043501) | 3.17887836 |
| 83 | skeletal muscle tissue development (GO:0007519) | 3.17264913 |
| 84 | cardiac muscle contraction (GO:0060048) | 3.16923973 |
| 85 | muscle cell cellular homeostasis (GO:0046716) | 3.14647098 |
| 86 | triglyceride catabolic process (GO:0019433) | 3.11102814 |
| 87 | myotube cell development (GO:0014904) | 3.08525180 |
| 88 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.08140152 |
| 89 | muscle atrophy (GO:0014889) | 3.07500104 |
| 90 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.07054810 |
| 91 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.04207906 |
| 92 | sulfate transmembrane transport (GO:1902358) | 3.00989176 |
| 93 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.99054485 |
| 94 | negative regulation of stem cell proliferation (GO:2000647) | 2.96972082 |
| 95 | response to mercury ion (GO:0046689) | 2.95658660 |
| 96 | growth hormone receptor signaling pathway (GO:0060396) | 2.93516669 |
| 97 | * muscle organ development (GO:0007517) | 2.93243055 |
| 98 | myoblast fusion (GO:0007520) | 2.92769849 |
| 99 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.91925550 |
| 100 | * muscle structure development (GO:0061061) | 2.91512987 |
| 101 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.88822854 |
| 102 | intracellular lipid transport (GO:0032365) | 2.88562043 |
| 103 | cellular response to epinephrine stimulus (GO:0071872) | 2.85964531 |
| 104 | cell migration involved in heart development (GO:0060973) | 2.85914705 |
| 105 | positive regulation of glycogen metabolic process (GO:0070875) | 2.85112770 |
| 106 | positive regulation of myoblast differentiation (GO:0045663) | 2.84479804 |
| 107 | glomerular basement membrane development (GO:0032836) | 2.82522376 |
| 108 | negative regulation of BMP signaling pathway (GO:0030514) | 2.82176426 |
| 109 | muscle cell fate commitment (GO:0042693) | 2.80013710 |
| 110 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.79648012 |
| 111 | muscle tissue morphogenesis (GO:0060415) | 2.78726660 |
| 112 | fibroblast migration (GO:0010761) | 2.77858180 |
| 113 | regulation of striated muscle contraction (GO:0006942) | 2.77407335 |
| 114 | tyrosine metabolic process (GO:0006570) | 2.76966036 |
| 115 | neutral lipid catabolic process (GO:0046461) | 2.76657899 |
| 116 | acylglycerol catabolic process (GO:0046464) | 2.76657899 |
| 117 | striated muscle adaptation (GO:0014888) | 2.76464355 |
| 118 | muscle hypertrophy (GO:0014896) | 2.75700564 |
| 119 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.75514255 |
| 120 | positive regulation of glucose import (GO:0046326) | 2.75368676 |
| 121 | muscle fiber development (GO:0048747) | 2.75061667 |
| 122 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.73190212 |
| 123 | detection of calcium ion (GO:0005513) | 2.72611503 |
| 124 | heart trabecula formation (GO:0060347) | 2.71116306 |
| 125 | striated muscle contraction (GO:0006941) | 2.70891057 |
| 126 | regulation of actin filament-based movement (GO:1903115) | 2.70796675 |
| 127 | protein hydroxylation (GO:0018126) | 2.70493776 |
| 128 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.69604700 |
| 129 | collagen catabolic process (GO:0030574) | 2.69201542 |
| 130 | ribonucleoprotein complex disassembly (GO:0032988) | 2.68461987 |
| 131 | regulation of sulfur metabolic process (GO:0042762) | 2.68347453 |
| 132 | collagen metabolic process (GO:0032963) | 2.67557849 |
| 133 | response to epinephrine (GO:0071871) | 2.67211931 |
| 134 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65808653 |
| 135 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.65341151 |
| 136 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.65324164 |
| 137 | axon extension involved in axon guidance (GO:0048846) | 2.65324164 |
| 138 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.62947826 |
| 139 | regulation of tight junction assembly (GO:2000810) | 2.62424199 |
| 140 | fatty acid oxidation (GO:0019395) | 2.60885206 |
| 141 | cardiac muscle hypertrophy (GO:0003300) | 2.59724503 |
| 142 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.59601197 |
| 143 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.59316033 |
| 144 | cardiac muscle cell proliferation (GO:0060038) | 2.58377688 |
| 145 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.58195918 |
| 146 | adult heart development (GO:0007512) | 2.58033913 |
| 147 | creatine metabolic process (GO:0006600) | 2.57443195 |
| 148 | fatty acid catabolic process (GO:0009062) | 2.56811194 |
| 149 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.56753169 |
| 150 | muscle contraction (GO:0006936) | 2.56743432 |
| 151 | protein targeting to plasma membrane (GO:0072661) | 2.54515506 |
| 152 | chondrocyte proliferation (GO:0035988) | 2.54082263 |
| 153 | lipid oxidation (GO:0034440) | 2.53893444 |
| 154 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.53283482 |
| 155 | glomerular filtration (GO:0003094) | 2.52507170 |
| 156 | fatty acid homeostasis (GO:0055089) | 2.50848913 |
| 157 | striated muscle hypertrophy (GO:0014897) | 2.50809406 |
| 158 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.50731564 |
| 159 | heart morphogenesis (GO:0003007) | 2.49564823 |
| 160 | nucleus localization (GO:0051647) | 2.48714755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.00954778 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.06463339 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.43282880 |
| 4 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.19365930 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.19159887 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.57539695 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.53970128 |
| 8 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.50037220 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.44418681 |
| 10 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.34084450 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.27598296 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.18091359 |
| 13 | CJUN_26792858_Chip-Seq_BT549_Human | 2.16025534 |
| 14 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.12393105 |
| 15 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09945109 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.09613616 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01277179 |
| 18 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95598011 |
| 19 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.95078031 |
| 20 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.95078031 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89808041 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.82860251 |
| 23 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.82815906 |
| 24 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.78676990 |
| 25 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.78676990 |
| 26 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.73780886 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.72001076 |
| 28 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.72001076 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69208062 |
| 30 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.67796651 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64917574 |
| 32 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.64905152 |
| 33 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.62883405 |
| 34 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61207912 |
| 35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59243812 |
| 36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58731204 |
| 37 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58403806 |
| 38 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.58110891 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55532809 |
| 40 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.52526222 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.49067684 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.48727191 |
| 43 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.47629341 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.46656341 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46471240 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42668011 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42308040 |
| 48 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.41837426 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38193542 |
| 50 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.37605429 |
| 51 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36495536 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35716922 |
| 53 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.35364083 |
| 54 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.34983584 |
| 55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.34788077 |
| 56 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.33767345 |
| 57 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32061198 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31620780 |
| 59 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31126630 |
| 60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.30351629 |
| 61 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29399573 |
| 62 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.28243864 |
| 63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.27931824 |
| 64 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27423632 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27101927 |
| 66 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26786729 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.25627297 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.25337689 |
| 69 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.25204165 |
| 70 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.25150492 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24886378 |
| 72 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.24732672 |
| 73 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.23726555 |
| 74 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23176620 |
| 75 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22620481 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.22592177 |
| 77 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.22577129 |
| 78 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22491123 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.21032771 |
| 80 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.20443161 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19999989 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19789923 |
| 83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18771796 |
| 84 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.18673257 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.18660069 |
| 86 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18596526 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17378816 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15465725 |
| 89 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15036165 |
| 90 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.14481544 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.13776614 |
| 92 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.12937677 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12923130 |
| 94 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12538211 |
| 95 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11304022 |
| 96 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10104471 |
| 97 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09754158 |
| 98 | RXR_22108803_ChIP-Seq_LS180_Human | 1.09679434 |
| 99 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.09569632 |
| 100 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.09004207 |
| 101 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.06590980 |
| 102 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05131850 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.04771446 |
| 104 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04627598 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04338441 |
| 106 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04148106 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.03889283 |
| 108 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03696365 |
| 109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03616574 |
| 110 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02730742 |
| 111 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.02702028 |
| 112 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.02282263 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.02025125 |
| 114 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.01698985 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.01614954 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.00776970 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.99785401 |
| 118 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.99368423 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99276396 |
| 120 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98693678 |
| 121 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98267373 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98060310 |
| 123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97383029 |
| 124 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97010656 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96896694 |
| 126 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96368650 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95688583 |
| 128 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95588822 |
| 129 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.94506516 |
| 130 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93672790 |
| 131 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92611041 |
| 132 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89875262 |
| 133 | * AR_19668381_ChIP-Seq_PC3_Human | 0.89623378 |
| 134 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89237192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.41651470 |
| 2 | MP0003136_yellow_coat_color | 4.62914822 |
| 3 | * MP0002837_dystrophic_cardiac_calcinosis | 4.43879848 |
| 4 | MP0005670_abnormal_white_adipose | 4.37052858 |
| 5 | MP0005275_abnormal_skin_tensile | 3.68120362 |
| 6 | MP0000751_myopathy | 3.67158587 |
| 7 | MP0003646_muscle_fatigue | 3.57352595 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.19318606 |
| 9 | MP0004130_abnormal_muscle_cell | 3.11605633 |
| 10 | MP0004084_abnormal_cardiac_muscle | 2.96671146 |
| 11 | MP0004215_abnormal_myocardial_fiber | 2.89623734 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.84259214 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.68156731 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.60484195 |
| 15 | MP0004272_abnormal_basement_membrane | 2.58045461 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.53192458 |
| 17 | * MP0000749_muscle_degeneration | 2.46461630 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.43207101 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.27473091 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.26711557 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.24993501 |
| 22 | MP0008775_abnormal_heart_ventricle | 2.19350093 |
| 23 | MP0000750_abnormal_muscle_regeneration | 2.16335361 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.08930232 |
| 25 | MP0004145_abnormal_muscle_electrophysio | 2.07871152 |
| 26 | * MP0005330_cardiomyopathy | 2.06073876 |
| 27 | * MP0005620_abnormal_muscle_contractility | 2.02855411 |
| 28 | MP0000003_abnormal_adipose_tissue | 1.99150510 |
| 29 | MP0002972_abnormal_cardiac_muscle | 1.98203716 |
| 30 | MP0003279_aneurysm | 1.95045093 |
| 31 | MP0003879_abnormal_hair_cell | 1.92454557 |
| 32 | MP0002108_abnormal_muscle_morphology | 1.86620164 |
| 33 | MP0004484_altered_response_of | 1.78846308 |
| 34 | * MP0000759_abnormal_skeletal_muscle | 1.77978858 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.77365094 |
| 36 | MP0006138_congestive_heart_failure | 1.75094972 |
| 37 | MP0003950_abnormal_plasma_membrane | 1.68267641 |
| 38 | MP0009384_cardiac_valve_regurgitation | 1.63431810 |
| 39 | * MP0002106_abnormal_muscle_physiology | 1.60002708 |
| 40 | * MP0001544_abnormal_cardiovascular_syste | 1.59203645 |
| 41 | * MP0005385_cardiovascular_system_phenoty | 1.59203645 |
| 42 | * MP0005369_muscle_phenotype | 1.55712961 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.54582477 |
| 44 | MP0010630_abnormal_cardiac_muscle | 1.52962904 |
| 45 | MP0001958_emphysema | 1.49276084 |
| 46 | MP0002971_abnormal_brown_adipose | 1.47310051 |
| 47 | MP0000747_muscle_weakness | 1.45214871 |
| 48 | MP0004381_abnormal_hair_follicle | 1.44293943 |
| 49 | * MP0002269_muscular_atrophy | 1.44270989 |
| 50 | * MP0003137_abnormal_impulse_conducting | 1.43471312 |
| 51 | MP0003828_pulmonary_edema | 1.37848134 |
| 52 | MP0009115_abnormal_fat_cell | 1.31072868 |
| 53 | MP0009250_abnormal_appendicular_skeleto | 1.30997470 |
| 54 | MP0006054_spinal_hemorrhage | 1.25845979 |
| 55 | MP0001299_abnormal_eye_distance/ | 1.24908388 |
| 56 | MP0004510_myositis | 1.24633570 |
| 57 | MP0004233_abnormal_muscle_weight | 1.21792086 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.17217142 |
| 59 | MP0005334_abnormal_fat_pad | 1.17163266 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.15964078 |
| 61 | MP0001542_abnormal_bone_strength | 1.11677172 |
| 62 | MP0004085_abnormal_heartbeat | 1.10791069 |
| 63 | MP0000733_abnormal_muscle_development | 1.09833715 |
| 64 | MP0002060_abnormal_skin_morphology | 1.08957299 |
| 65 | MP0002938_white_spotting | 1.08171077 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.07846328 |
| 67 | MP0000534_abnormal_ureter_morphology | 1.07685727 |
| 68 | MP0002295_abnormal_pulmonary_circulatio | 1.07632330 |
| 69 | MP0005623_abnormal_meninges_morphology | 1.03355032 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 1.00927521 |
| 71 | MP0003959_abnormal_lean_body | 1.00761965 |
| 72 | MP0004134_abnormal_chest_morphology | 1.00588638 |
| 73 | MP0010368_abnormal_lymphatic_system | 0.97828302 |
| 74 | MP0005508_abnormal_skeleton_morphology | 0.97491754 |
| 75 | MP0003385_abnormal_body_wall | 0.95906142 |
| 76 | MP0001661_extended_life_span | 0.92968853 |
| 77 | MP0002970_abnormal_white_adipose | 0.92257265 |
| 78 | * MP0003045_fibrosis | 0.91263986 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 0.88413099 |
| 80 | MP0004270_analgesia | 0.87076243 |
| 81 | MP0005165_increased_susceptibility_to | 0.83831343 |
| 82 | MP0002075_abnormal_coat/hair_pigmentati | 0.82808304 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.82410253 |
| 84 | MP0001879_abnormal_lymphatic_vessel | 0.81313099 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.81147679 |
| 86 | MP0000343_altered_response_to | 0.80584103 |
| 87 | MP0000163_abnormal_cartilage_morphology | 0.80222841 |
| 88 | * MP0000266_abnormal_heart_morphology | 0.80125462 |
| 89 | MP0005451_abnormal_body_composition | 0.78096210 |
| 90 | MP0002127_abnormal_cardiovascular_syste | 0.77759574 |
| 91 | MP0005595_abnormal_vascular_smooth | 0.76380274 |
| 92 | MP0002876_abnormal_thyroid_physiology | 0.73961128 |
| 93 | MP0002128_abnormal_blood_circulation | 0.72732229 |
| 94 | MP0002095_abnormal_skin_pigmentation | 0.70966281 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.69775312 |
| 96 | MP0002115_abnormal_skeleton_extremities | 0.69677437 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.68249612 |
| 98 | MP0003091_abnormal_cell_migration | 0.67292593 |
| 99 | MP0004147_increased_porphyrin_level | 0.66179220 |
| 100 | * MP0002168_other_aberrant_phenotype | 0.65237582 |
| 101 | MP0005535_abnormal_body_temperature | 0.65117550 |
| 102 | MP0002078_abnormal_glucose_homeostasis | 0.64376789 |
| 103 | MP0000767_abnormal_smooth_muscle | 0.64307367 |
| 104 | MP0003941_abnormal_skin_development | 0.62260055 |
| 105 | MP0005452_abnormal_adipose_tissue | 0.61225222 |
| 106 | MP0010030_abnormal_orbit_morphology | 0.60846794 |
| 107 | MP0005388_respiratory_system_phenotype | 0.60068431 |
| 108 | MP0002133_abnormal_respiratory_system | 0.60068431 |
| 109 | MP0005171_absent_coat_pigmentation | 0.60030494 |
| 110 | MP0003935_abnormal_craniofacial_develop | 0.59935911 |
| 111 | MP0005085_abnormal_gallbladder_physiolo | 0.59238541 |
| 112 | MP0002909_abnormal_adrenal_gland | 0.58821865 |
| 113 | MP0003948_abnormal_gas_homeostasis | 0.57929798 |
| 114 | MP0008569_lethality_at_weaning | 0.57674060 |
| 115 | MP0001186_pigmentation_phenotype | 0.56907650 |
| 116 | MP0001177_atelectasis | 0.56271033 |
| 117 | MP0002877_abnormal_melanocyte_morpholog | 0.56221243 |
| 118 | MP0003937_abnormal_limbs/digits/tail_de | 0.54756405 |
| 119 | MP0005266_abnormal_metabolism | 0.53674981 |
| 120 | MP0000428_abnormal_craniofacial_morphol | 0.52798333 |
| 121 | MP0002249_abnormal_larynx_morphology | 0.52471724 |
| 122 | MP0003942_abnormal_urinary_system | 0.51395898 |
| 123 | MP0005448_abnormal_energy_balance | 0.51018092 |
| 124 | MP0003755_abnormal_palate_morphology | 0.50871989 |
| 125 | * MP0001614_abnormal_blood_vessel | 0.50566543 |
| 126 | MP0000015_abnormal_ear_pigmentation | 0.49386137 |
| 127 | MP0005174_abnormal_tail_pigmentation | 0.44718789 |
| 128 | MP0002138_abnormal_hepatobiliary_system | 0.40908730 |
| 129 | MP0008770_decreased_survivor_rate | 0.39617163 |
| 130 | MP0002160_abnormal_reproductive_system | 0.38859726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 4.88719550 |
| 2 | Increased connective tissue (HP:0009025) | 4.82667642 |
| 3 | Sudden death (HP:0001699) | 4.69799515 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 4.35842154 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.30617684 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 4.28164888 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.13775635 |
| 8 | * Lipoatrophy (HP:0100578) | 4.13229449 |
| 9 | Ulnar deviation of the wrist (HP:0003049) | 4.09576535 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 4.04163240 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 3.97303765 |
| 12 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.95975776 |
| 13 | Exercise-induced myalgia (HP:0003738) | 3.90187554 |
| 14 | Ventricular tachycardia (HP:0004756) | 3.77284644 |
| 15 | Atrial fibrillation (HP:0005110) | 3.65252218 |
| 16 | Myoglobinuria (HP:0002913) | 3.60945525 |
| 17 | Difficulty running (HP:0009046) | 3.56257866 |
| 18 | Oligomenorrhea (HP:0000876) | 3.54222518 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.52809054 |
| 20 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.52483250 |
| 21 | Broad metatarsal (HP:0001783) | 3.51601332 |
| 22 | Increased variability in muscle fiber diameter (HP:0003557) | 3.45098121 |
| 23 | Calcaneovalgus deformity (HP:0001848) | 3.44443469 |
| 24 | Focal motor seizures (HP:0011153) | 3.43101612 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 3.42668141 |
| 26 | Hypoplastic ischia (HP:0003175) | 3.36449191 |
| 27 | Spinal rigidity (HP:0003306) | 3.36134338 |
| 28 | Primary atrial arrhythmia (HP:0001692) | 3.34122106 |
| 29 | Ankle contracture (HP:0006466) | 3.30318508 |
| 30 | Deformed tarsal bones (HP:0008119) | 3.25261544 |
| 31 | Myotonia (HP:0002486) | 3.14675623 |
| 32 | Abnormality of the ischium (HP:0003174) | 3.14242283 |
| 33 | Supraventricular arrhythmia (HP:0005115) | 3.13360069 |
| 34 | Supraventricular tachycardia (HP:0004755) | 3.12733069 |
| 35 | Myopathic facies (HP:0002058) | 3.10847370 |
| 36 | Amelogenesis imperfecta (HP:0000705) | 3.08463926 |
| 37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.04429402 |
| 38 | Aortic aneurysm (HP:0004942) | 3.04099443 |
| 39 | Aortic dissection (HP:0002647) | 2.99892524 |
| 40 | Cerebral aneurysm (HP:0004944) | 2.91291264 |
| 41 | Absent phalangeal crease (HP:0006109) | 2.89240035 |
| 42 | Shallow orbits (HP:0000586) | 2.85598137 |
| 43 | Malignant hyperthermia (HP:0002047) | 2.85512399 |
| 44 | * Dilated cardiomyopathy (HP:0001644) | 2.84621422 |
| 45 | Acanthosis nigricans (HP:0000956) | 2.78509431 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.78466215 |
| 47 | EMG: myopathic abnormalities (HP:0003458) | 2.73931301 |
| 48 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.71056367 |
| 49 | Popliteal pterygium (HP:0009756) | 2.68130086 |
| 50 | EMG: neuropathic changes (HP:0003445) | 2.67769184 |
| 51 | Soft skin (HP:0000977) | 2.65617472 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.63865601 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.63819718 |
| 54 | Overgrowth (HP:0001548) | 2.62801175 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62477007 |
| 56 | Follicular hyperkeratosis (HP:0007502) | 2.61919182 |
| 57 | Muscle fiber inclusion bodies (HP:0100299) | 2.60627518 |
| 58 | Atrophic scars (HP:0001075) | 2.57249040 |
| 59 | Prolonged QT interval (HP:0001657) | 2.56417023 |
| 60 | Difficulty climbing stairs (HP:0003551) | 2.55802160 |
| 61 | Hyperglycemia (HP:0003074) | 2.53613957 |
| 62 | Subaortic stenosis (HP:0001682) | 2.53340648 |
| 63 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.53340648 |
| 64 | Areflexia of lower limbs (HP:0002522) | 2.44018106 |
| 65 | Cervical subluxation (HP:0003308) | 2.43045979 |
| 66 | Abnormal finger flexion creases (HP:0006143) | 2.42780186 |
| 67 | Bundle branch block (HP:0011710) | 2.42697137 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.42664748 |
| 69 | * Scapular winging (HP:0003691) | 2.37181272 |
| 70 | Bladder diverticulum (HP:0000015) | 2.32633226 |
| 71 | Fatigable weakness (HP:0003473) | 2.29824238 |
| 72 | Abnormality of the neuromuscular junction (HP:0003398) | 2.29824238 |
| 73 | Type 2 muscle fiber atrophy (HP:0003554) | 2.26716219 |
| 74 | Vertebral arch anomaly (HP:0008438) | 2.26468397 |
| 75 | Ulnar bowing (HP:0003031) | 2.25879545 |
| 76 | Limited hip movement (HP:0008800) | 2.25554584 |
| 77 | Hip contracture (HP:0003273) | 2.25314504 |
| 78 | Tarsal synostosis (HP:0008368) | 2.25020402 |
| 79 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.23433365 |
| 80 | Round ear (HP:0100830) | 2.22747359 |
| 81 | Frequent falls (HP:0002359) | 2.21773131 |
| 82 | Dilatation of the ascending aorta (HP:0005111) | 2.20539908 |
| 83 | Muscular dystrophy (HP:0003560) | 2.20366615 |
| 84 | Generalized muscle weakness (HP:0003324) | 2.19896302 |
| 85 | Ventricular arrhythmia (HP:0004308) | 2.19125321 |
| 86 | Syncope (HP:0001279) | 2.18546206 |
| 87 | Broad ribs (HP:0000885) | 2.16976785 |
| 88 | Fragile skin (HP:0001030) | 2.16714229 |
| 89 | Aneurysm (HP:0002617) | 2.15356726 |
| 90 | Rectal prolapse (HP:0002035) | 2.14612375 |
| 91 | Nemaline bodies (HP:0003798) | 2.14421721 |
| 92 | Distal arthrogryposis (HP:0005684) | 2.11249036 |
| 93 | Slender build (HP:0001533) | 2.10090466 |
| 94 | Acanthocytosis (HP:0001927) | 2.09583590 |
| 95 | Asymmetric septal hypertrophy (HP:0001670) | 2.09130244 |
| 96 | Neck muscle weakness (HP:0000467) | 2.08618609 |
| 97 | Weak cry (HP:0001612) | 2.07560110 |
| 98 | Bell-shaped thorax (HP:0001591) | 2.06854227 |
| 99 | Palpitations (HP:0001962) | 2.05405921 |
| 100 | Synostosis involving bones of the lower limbs (HP:0009138) | 2.03966718 |
| 101 | Synostosis involving bones of the feet (HP:0009140) | 2.03966718 |
| 102 | Nonprogressive disorder (HP:0003680) | 2.02391204 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 1.99950809 |
| 104 | Muscle stiffness (HP:0003552) | 1.98563027 |
| 105 | Mitral valve prolapse (HP:0001634) | 1.97117866 |
| 106 | Steppage gait (HP:0003376) | 1.96566606 |
| 107 | Abnormal atrioventricular conduction (HP:0005150) | 1.96442258 |
| 108 | Bulbar palsy (HP:0001283) | 1.95623340 |
| 109 | Breech presentation (HP:0001623) | 1.95279031 |
| 110 | Muscle fiber atrophy (HP:0100295) | 1.94949273 |
| 111 | Hypoplasia of the iris (HP:0007676) | 1.94588307 |
| 112 | Wormian bones (HP:0002645) | 1.94581532 |
| 113 | Bradycardia (HP:0001662) | 1.93117440 |
| 114 | Abnormality of the foot musculature (HP:0001436) | 1.91679903 |
| 115 | Wrist flexion contracture (HP:0001239) | 1.91219327 |
| 116 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.90176103 |
| 117 | Hypoalphalipoproteinemia (HP:0003233) | 1.89783839 |
| 118 | Atrioventricular block (HP:0001678) | 1.88891258 |
| 119 | Ulnar deviation of finger (HP:0009465) | 1.88840564 |
| 120 | Metatarsus adductus (HP:0001840) | 1.88660618 |
| 121 | Vascular tortuosity (HP:0004948) | 1.88509795 |
| 122 | Aplasia of the musculature (HP:0100854) | 1.88161740 |
| 123 | Foot dorsiflexor weakness (HP:0009027) | 1.88109833 |
| 124 | Insulin resistance (HP:0000855) | 1.87927532 |
| 125 | Facial diplegia (HP:0001349) | 1.87636741 |
| 126 | Arterial tortuosity (HP:0005116) | 1.87081382 |
| 127 | Limb-girdle muscle weakness (HP:0003325) | 1.84803512 |
| 128 | Neonatal short-limb short stature (HP:0008921) | 1.83139337 |
| 129 | Toxemia of pregnancy (HP:0100603) | 1.80624880 |
| 130 | Heart block (HP:0012722) | 1.79811046 |
| 131 | Blue sclerae (HP:0000592) | 1.77475584 |
| 132 | Hypoglycemic coma (HP:0001325) | 1.76155382 |
| 133 | Distal lower limb amyotrophy (HP:0008944) | 1.76036568 |
| 134 | Rimmed vacuoles (HP:0003805) | 1.75027961 |
| 135 | Abnormality of dentin (HP:0010299) | 1.73681539 |
| 136 | Ketoacidosis (HP:0001993) | 1.71191967 |
| 137 | Genu recurvatum (HP:0002816) | 1.70799195 |
| 138 | Venous abnormality (HP:0002624) | 1.70582179 |
| 139 | Decreased subcutaneous fat (HP:0001002) | 1.70326046 |
| 140 | Gowers sign (HP:0003391) | 1.68820400 |
| 141 | Hyperextensible skin (HP:0000974) | 1.68056585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.23907530 |
| 2 | OBSCN | 3.86757675 |
| 3 | SIK1 | 3.37728422 |
| 4 | CAMK1D | 3.28870390 |
| 5 | TRIB3 | 3.16735677 |
| 6 | PIK3CA | 2.86755711 |
| 7 | LATS1 | 2.84588894 |
| 8 | LMTK2 | 2.64458897 |
| 9 | DDR2 | 2.63947957 |
| 10 | CAMK1G | 2.46814964 |
| 11 | PHKG1 | 2.46043134 |
| 12 | PHKG2 | 2.46043134 |
| 13 | PDK3 | 2.38009108 |
| 14 | PDK4 | 2.38009108 |
| 15 | DMPK | 2.35343505 |
| 16 | STK38L | 2.15196429 |
| 17 | PDGFRA | 1.98689183 |
| 18 | BCKDK | 1.76725799 |
| 19 | EPHA3 | 1.75931688 |
| 20 | LATS2 | 1.74372968 |
| 21 | NLK | 1.72593456 |
| 22 | MYLK | 1.60694894 |
| 23 | ZAK | 1.60563956 |
| 24 | FRK | 1.55882673 |
| 25 | PRKAA2 | 1.50425556 |
| 26 | PKN2 | 1.40257967 |
| 27 | INSRR | 1.36129762 |
| 28 | TGFBR2 | 1.35660921 |
| 29 | MAP2K2 | 1.33403198 |
| 30 | PDK2 | 1.32161763 |
| 31 | TRPM7 | 1.31972136 |
| 32 | EPHB2 | 1.30672284 |
| 33 | PINK1 | 1.29429329 |
| 34 | NEK9 | 1.21457083 |
| 35 | ACVR1B | 1.19616055 |
| 36 | RIPK1 | 1.19586948 |
| 37 | PAK3 | 1.13931495 |
| 38 | STK24 | 1.10668772 |
| 39 | PRKAA1 | 1.08100190 |
| 40 | ROCK1 | 1.07248992 |
| 41 | MAP3K6 | 1.06488827 |
| 42 | CDC42BPA | 1.01178928 |
| 43 | GRK7 | 0.99725966 |
| 44 | MUSK | 0.98245719 |
| 45 | FGFR2 | 0.96068552 |
| 46 | KSR2 | 0.93404681 |
| 47 | MAP3K4 | 0.93377788 |
| 48 | RET | 0.91457942 |
| 49 | PRKD3 | 0.89391526 |
| 50 | PRKD1 | 0.87588702 |
| 51 | PAK6 | 0.85907631 |
| 52 | FER | 0.85810475 |
| 53 | PDPK1 | 0.83591924 |
| 54 | BMPR1B | 0.81988063 |
| 55 | MAPKAPK3 | 0.80640527 |
| 56 | MARK1 | 0.79922651 |
| 57 | MAP3K3 | 0.78480505 |
| 58 | STK3 | 0.78151166 |
| 59 | FGFR3 | 0.76940801 |
| 60 | TIE1 | 0.75322043 |
| 61 | PDGFRB | 0.74979274 |
| 62 | STK38 | 0.71659760 |
| 63 | MAPK7 | 0.70512296 |
| 64 | PAK2 | 0.68741138 |
| 65 | MAP3K2 | 0.68552563 |
| 66 | ERBB3 | 0.66846654 |
| 67 | PRKCH | 0.64963335 |
| 68 | MTOR | 0.64747345 |
| 69 | MAP2K1 | 0.62394544 |
| 70 | ADRBK1 | 0.62305844 |
| 71 | ILK | 0.61002908 |
| 72 | CAMK2D | 0.60055477 |
| 73 | CDK9 | 0.57925361 |
| 74 | PTK2B | 0.56375939 |
| 75 | JAK1 | 0.54921074 |
| 76 | WNK1 | 0.53578636 |
| 77 | PIK3CG | 0.51753574 |
| 78 | MAP2K4 | 0.50915659 |
| 79 | EEF2K | 0.50609017 |
| 80 | PRKCE | 0.49825107 |
| 81 | MET | 0.49598604 |
| 82 | TGFBR1 | 0.49258205 |
| 83 | SGK2 | 0.49069922 |
| 84 | SGK3 | 0.47118623 |
| 85 | CAMK2G | 0.47046112 |
| 86 | FLT3 | 0.42961550 |
| 87 | NEK1 | 0.42523596 |
| 88 | NUAK1 | 0.42314322 |
| 89 | MAP3K5 | 0.42288373 |
| 90 | MAP3K7 | 0.41065773 |
| 91 | CAMK2B | 0.40673165 |
| 92 | AKT2 | 0.40453755 |
| 93 | EIF2AK2 | 0.39757814 |
| 94 | CAMK1 | 0.39621758 |
| 95 | MARK2 | 0.38709297 |
| 96 | PRKACG | 0.38092017 |
| 97 | LIMK1 | 0.37762706 |
| 98 | ROCK2 | 0.37389932 |
| 99 | PRKD2 | 0.36665645 |
| 100 | MST1R | 0.36098574 |
| 101 | MELK | 0.35483464 |
| 102 | IGF1R | 0.35236781 |
| 103 | GRK5 | 0.33396183 |
| 104 | FGFR1 | 0.32745301 |
| 105 | NEK2 | 0.30990073 |
| 106 | PTK2 | 0.30605350 |
| 107 | RPS6KB1 | 0.29457277 |
| 108 | PRKACA | 0.29178836 |
| 109 | PRKG1 | 0.28835442 |
| 110 | AKT3 | 0.28711222 |
| 111 | PKN1 | 0.28126880 |
| 112 | MAPK12 | 0.27837328 |
| 113 | MAP2K3 | 0.27775042 |
| 114 | MAPK11 | 0.27560882 |
| 115 | SGK1 | 0.26916378 |
| 116 | CAMK4 | 0.26876481 |
| 117 | GSK3A | 0.26414853 |
| 118 | CAMK2A | 0.26299046 |
| 119 | PLK2 | 0.26187693 |
| 120 | NME1 | 0.26041962 |
| 121 | MOS | 0.25616953 |
| 122 | EIF2AK3 | 0.23861347 |
| 123 | MAPKAPK5 | 0.23819476 |
| 124 | DAPK3 | 0.22550040 |
| 125 | DAPK2 | 0.21979075 |
| 126 | CSNK1A1L | 0.21589192 |
| 127 | KIT | 0.21421495 |
| 128 | PRKG2 | 0.20915972 |
| 129 | CCNB1 | 0.20460307 |
| 130 | MAPK4 | 0.19142224 |
| 131 | PRKACB | 0.17659677 |
| 132 | STK11 | 0.16782587 |
| 133 | NTRK1 | 0.15887757 |
| 134 | TAF1 | 0.14213227 |
| 135 | IRAK3 | 0.13354694 |
| 136 | ABL1 | 0.10464932 |
| 137 | MAPK3 | 0.09405806 |
| 138 | CSNK1D | 0.09035016 |
| 139 | RPS6KA3 | 0.08946332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 6.35452215 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.32998062 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.49796005 |
| 4 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06300715 |
| 5 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.03882137 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.97476318 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.57969489 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.53423972 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.48037613 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.47281396 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43700489 |
| 12 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.41874252 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38064386 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.32335541 |
| 15 | Phototransduction_Homo sapiens_hsa04744 | 2.08636194 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92800241 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.92438471 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.89801948 |
| 19 | Focal adhesion_Homo sapiens_hsa04510 | 1.88644429 |
| 20 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.78082946 |
| 21 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.61305558 |
| 22 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.58997920 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.58378250 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.47183140 |
| 25 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.43430068 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.38458775 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.35477964 |
| 28 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.31558954 |
| 29 | Adherens junction_Homo sapiens_hsa04520 | 1.29784032 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.27918617 |
| 31 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.21078218 |
| 32 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.17910060 |
| 33 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.16978653 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14253162 |
| 35 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12089902 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.10125035 |
| 37 | Morphine addiction_Homo sapiens_hsa05032 | 1.08741641 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.02520097 |
| 39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.02066302 |
| 40 | Renin secretion_Homo sapiens_hsa04924 | 1.01151872 |
| 41 | GABAergic synapse_Homo sapiens_hsa04727 | 1.00601791 |
| 42 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98887181 |
| 43 | * Viral myocarditis_Homo sapiens_hsa05416 | 0.98104680 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98078952 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96117793 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.95923479 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.95170812 |
| 48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90637631 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 0.90588285 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.89677559 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86696465 |
| 52 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.86134034 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82384760 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81671050 |
| 55 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.80450244 |
| 56 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.80085835 |
| 57 | Gap junction_Homo sapiens_hsa04540 | 0.76820134 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.75673851 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.74430835 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74123988 |
| 61 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71919264 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71804845 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70833058 |
| 64 | Salivary secretion_Homo sapiens_hsa04970 | 0.70395255 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70363254 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70158465 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69699951 |
| 68 | Melanoma_Homo sapiens_hsa05218 | 0.68932237 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65095498 |
| 70 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64403915 |
| 71 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.64041597 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64039084 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62941865 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62423789 |
| 75 | Parkinsons disease_Homo sapiens_hsa05012 | 0.61689831 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61538531 |
| 77 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.61157028 |
| 78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.60777806 |
| 79 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60523973 |
| 80 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59433291 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58979553 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58421596 |
| 83 | Insulin secretion_Homo sapiens_hsa04911 | 0.58266358 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57543321 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56517512 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.55330943 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54113041 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53874320 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53821326 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.53692054 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53504269 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51240060 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51124538 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51012105 |
| 95 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49504915 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48824479 |
| 97 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48423535 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48191582 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48113034 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.47978122 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47908737 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.47354107 |
| 103 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46593682 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.46534120 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46186454 |
| 106 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46150667 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45748504 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44748109 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44299814 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.44243072 |
| 111 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43448060 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.43212390 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42906122 |
| 114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42830308 |
| 115 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42142408 |
| 116 | Pathways in cancer_Homo sapiens_hsa05200 | 0.42090815 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41397618 |
| 118 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40998987 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40672259 |
| 120 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40139161 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40082010 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39481967 |
| 123 | Peroxisome_Homo sapiens_hsa04146 | 0.38784274 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38424045 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.38276595 |
| 126 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37906455 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36613243 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.36091993 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36027948 |
| 130 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.35951633 |
| 131 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35726548 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.35068377 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34703144 |
| 134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34427665 |
| 135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34071049 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.33286253 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33075999 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32942168 |

